Hitoshi Suzushima

4.0k total citations · 1 hit paper
57 papers, 1.9k citations indexed

About

Hitoshi Suzushima is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Hematology. According to data from OpenAlex, Hitoshi Suzushima has authored 57 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 17 papers in Ecology, Evolution, Behavior and Systematics and 17 papers in Hematology. Recurrent topics in Hitoshi Suzushima's work include T-cell and Retrovirus Studies (25 papers), Vector-Borne Animal Diseases (17 papers) and Acute Myeloid Leukemia Research (15 papers). Hitoshi Suzushima is often cited by papers focused on T-cell and Retrovirus Studies (25 papers), Vector-Borne Animal Diseases (17 papers) and Acute Myeloid Leukemia Research (15 papers). Hitoshi Suzushima collaborates with scholars based in Japan, United States and United Kingdom. Hitoshi Suzushima's co-authors include Norio Asou, Kiyoshi Takatsuki, Motomi Osato, Toshio Hattori, Toshiya Okubo, Koyu Hoshino, Atae Utsunomiya, Yoshiaki Ito, Shinichiro Yoshida and Akihiko Sakashita and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hitoshi Suzushima

56 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

2012 478 citations Takashi Ishida, Kazuhito Yamamoto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hitoshi Suzushima Japan	19	1.0k	571	561	496	409	57	1.9k
Michihiro Hidaka Japan	25	732 0.7×	658 1.2×	393 0.7×	238 0.5×	168 0.4×	88	1.7k
Yoshitaka Imaizumi Japan	23	1.2k 1.2×	169 0.3×	367 0.7×	664 1.3×	508 1.2×	111	1.9k
Mitsuo Kozuru Japan	16	563 0.6×	220 0.4×	322 0.6×	310 0.6×	214 0.5×	58	1.2k
Ilseung Choi Japan	22	935 0.9×	220 0.4×	213 0.4×	413 0.8×	328 0.8×	99	1.7k
F Sigaux France	23	634 0.6×	697 1.2×	515 0.9×	114 0.2×	116 0.3×	43	1.7k
Masakatsu Hishizawa Japan	20	758 0.8×	185 0.3×	413 0.7×	239 0.5×	198 0.5×	70	1.6k
Atsushi Wakita Japan	15	408 0.4×	483 0.8×	329 0.6×	116 0.2×	82 0.2×	53	1.2k
Shinichiro Yoshida Japan	16	709 0.7×	162 0.3×	218 0.4×	346 0.7×	256 0.6×	65	1.2k
Shirley G. Quan United States	12	1.5k 1.5×	261 0.5×	320 0.6×	277 0.6×	314 0.8×	16	1.9k
I Miyoshi Japan	17	283 0.3×	594 1.0×	1.2k 2.2×	132 0.3×	133 0.3×	77	2.1k

Countries citing papers authored by Hitoshi Suzushima

Since Specialization

Citations

This map shows the geographic impact of Hitoshi Suzushima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Suzushima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Suzushima more than expected).

Fields of papers citing papers by Hitoshi Suzushima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Suzushima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Suzushima. The network helps show where Hitoshi Suzushima may publish in the future.

Co-authorship network of co-authors of Hitoshi Suzushima

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Suzushima. A scholar is included among the top collaborators of Hitoshi Suzushima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Suzushima. Hitoshi Suzushima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tatetsu, Hiro, Yusuke Higuchi, Toshikazu Miyakawa, et al.. (2025). Prognostic impact of valemetostat in relapsed/refractory adult T‐cell leukaemia‐lymphoma. British Journal of Haematology. 208(1). 159–169.

Kawamoto, Keisuke, Hiroaki Miyoshi, Eriko Yanagida, et al.. (2017). Comparison of clinicopathological characteristics between T‐cell prolymphocytic leukemia and peripheral T‐cell lymphoma, not otherwise specified. European Journal Of Haematology. 98(5). 459–466. 9 indexed citations

Ishida, Takashi, Atae Utsunomiya, Tatsuro Jo, et al.. (2017). Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies. Cancer Science. 108(10). 2022–2029. 52 indexed citations

Chagan‐Yasutan, Haorile, Yugo Ashino, Wakana Nakayama, et al.. (2017). Galectin-9 as a Predictive Marker for the Onset of Immune-Related Adverse Effects Associated with Anti-CCR4 MoAb Therapy in Patients with Adult T Cell Leukemia. The Tohoku Journal of Experimental Medicine. 241(3). 201–208. 9 indexed citations

Nakamura, Tadashi, et al.. (2014). Amyloid A amyloidosis in a Japanese patient with familial Mediterranean fever associated with homozygosity for the pyrin variant M694I/M694I. Modern Rheumatology. 24(2). 349–352. 5 indexed citations

Takamatsu, Yasushi, Junji Suzumiya, Atae Utsunomiya, et al.. (2010). THP‐COP regimen for the treatment of peripheral T‐cell lymphoma and adult T‐cell leukemia/lymphoma: a multicenter phase II study. European Journal Of Haematology. 84(5). 391–397. 14 indexed citations

Nanri, Tomoko, Naofumi Matsuno, Toshiro Kawakita, et al.. (2005). Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22). Leukemia. 19(8). 1361–1366. 72 indexed citations

Nanri, Tomoko, Naofumi Matsuno, Toshiro Kawakita, et al.. (2004). Mutations in the Receptor Tyrosine Kinase Pathway Are Associated with Clinical Outcome in Patients with Acute Myeloblastic Leukemia Harboring t(8;21)(q22;q22).. Blood. 104(11). 3000–3000. 1 indexed citations

Suzumiya, Junji, et al.. (2004). Phase I Study of the Combination of Irinotecan Hydrochloride, Carboplatin, and Dexamethasone for the Treatment of Relapsed or Refractory Malignant Lymphoma. International Journal of Hematology. 79(3). 266–270. 8 indexed citations

10.

Hoshino, Koyu, Norio Asou, Toshiya Okubo, et al.. (2002). The absence of the p15^INK4B gene alterations in adult patients with precursor B‐cell acute lymphoblastic leukaemia is a favourable prognostic factor. British Journal of Haematology. 117(3). 531–540. 20 indexed citations

11.

Yamaguchi, Kazunari, et al.. (2000). . Journal of the Japan Society of Blood Transfusion. 46(6). 517–520. 1 indexed citations

12.

Asou, Norio, Motomi Osato, Toshiya Okubo, et al.. (1998). Acute Myelomonoblastic Leukemia Carrying the PEBP2β/MYH11 Fusion Gene. Leukemia & lymphoma. 31(1-2). 81–91. 6 indexed citations

13.

Asou, Norio, Motomi Osato, Kentaro Horikawa, et al.. (1997). Burkitt's type acute lymphoblastic transformation associated with t(8;14) in a case of B cell chronic lymphocytic leukemia.. PubMed. 11(11). 1986–8. 10 indexed citations

14.

Osato, Motomi, Norio Asou, Toshiya Okubo, et al.. (1997). Myelomonoblastic leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34⁺, c‐KIT⁺ immature cells. British Journal of Haematology. 97(3). 656–658. 16 indexed citations

15.

Suzushima, Hitoshi, Norio Asou, Toshio Fujimoto, et al.. (1995). Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus. Blood. 85(2). 480–486. 24 indexed citations

16.

Mori, Shunsuke, Tatsuya Kawaguchi, Hiroaki Kakinuma, et al.. (1994). Alcaptonuria: A Case Complicated with Valvular Heart Disease and Immunodeficiency.. Internal Medicine. 33(8). 512–516. 5 indexed citations

17.

Tsuchiya, Hiroyuki, Masahiko Watanabe, Hitoshi Suzushima, et al.. (1993). Analysis of myeloid characteristics in acute lymphoblastic leukemia. Leukemia Research. 17(9). 809–813. 7 indexed citations

18.

Suzushima, Hitoshi, Shuzo Matsushita, Ryotaro Nakamura, et al.. (1992). DETECTION OF EPSTEIN‐BARR VIRAL DNA IN AGGRESSIVE CD8⁺ T CELL LEUKAEMIC CELLS. British Journal of Haematology. 82(4). 774–776. 4 indexed citations

19.

Asou, Norio, Kenji Tanaka, Michihiro Hidaka, et al.. (1992). Inversion of chromosome 16 and bone marrow eosinophilia in a myelomonocytic transformation of chronic myeloid leukemia. Cancer Genetics and Cytogenetics. 61(2). 197–200. 27 indexed citations

20.

Takatsuki, Kiyoshi, Toshio Hattori, K Yamaguchi, et al.. (1991). [Biomolecular aspects of adult T-cell leukemia].. PubMed. 18(7). 1112–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact